Share This Article:

Case Report: Normocalcemic Hyperparathyroidism

Abstract Full-Text HTML XML Download Download as PDF (Size:242KB) PP. 253-256
DOI: 10.4236/crcm.2014.35058    3,155 Downloads   4,497 Views   Citations


A case of normocalcemic hyperparathyroidism is diagnosed basing on the clinical manifestations & laborotary investigation supported by finding of unilateral parathyroid adenoma on imaging studies and the patient was referred for surgical exploration for the parathyroid adenoma.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Muhammed Mustafa, H. , Al Shekhani, M. and Jamal, B. (2014) Case Report: Normocalcemic Hyperparathyroidism. Case Reports in Clinical Medicine, 3, 253-256. doi: 10.4236/crcm.2014.35058.


[2] Díaz-Soto, G., Julián, M.T. and Puig-Domingo, M. (2012) Normocalcemic Primary Hyperparathyroidism: A Newly Emerging Disease Needing Therapeutic Intervention. Hormones (Athens), 11, 390-396.
[3] Koumakis, E., Souberbielle, J.C., Sarfati, E., Meunier, M., Maury, E., Gallimard, E., et al. (2013) Bone Mineral Density Evolution after Successful Parathyroidectomy in Patients with Normocalcemic Primary Hyperparathyroidism. The Journal of Clinical Endocrinology and Metabolism, 98, 3213-3220.
[4] Gupta, V. (2013) Normocalcemic Primary Hyperparathyroidism in a Patient with Severe Osteoporosis Receiving Teriparatide. Indian Journal of Endocrinology and Metabolism, 17, 336-338.
[5] Cusano, N.E., Maalouf, N.M., Wang, P.Y., Zhang, C., Cremers, S.C., Haney, E.M., et al. (2013) Normocalcemic Hyperparathyroidism and Hypoparathyroidism in Two Community-Based Nonreferral Populations. The Journal of Clinical Endocrinology and Metabolism, 98, 2734-2741.
[6] Martínez Díaz-Guerra, G., Jódar Gimeno, E., Reyes García, R., Gómez Sáez, J.M., Muñoz-Torres, M., et al. (2013) Normocalcemic Primary Hyperparathyroidism: Recommendations for Management and Follow-up. Endocrinological Nutrition, 60, e1-e6.
[7] Bilezikian, J.P. and Silverberg, S. (2010) Normocalcemic Primary Hyperparathyroidism. Arq Bras Endocrinological Metabology, 54, 106-109.
[8] Tachibana, S., Yokoi, T., Sato, S., Yanase, T. and Yamashita, H. (2013) Surgically Proven Normocalcemic Primary Hyperparathyroidism: Speculation of the Possible Role of Estrogen in the Etiology of This Disease in Premenopausal Women. Internal Medicine, 52, 781-785.
[9] Cusano, N.E., Silverberg, S.J. and Bilezikian, J.P. (2013) Normocalcemic Primary Hyperparathyroidism. Journal of Clinical Densitometry, 16, 33-39.
[10] Lewiecki, E.M. and Miller, P.D. (2013) Skeletal Effects of Primary Hyperparathyroidism: Bone Mineral Density and Fracture Risk. Journal of Clinical Densitometry, 16, 28-32.
[11] Grønli, O. and Wynn, R. (2013) Normocalcemic Hyperparathyroidism and Treatment Resistant Depression. Psychosomatics, 54, 493-497.
[12] Misiorowski, W. and Zgliczyński, W. (2012) Prevalence of Primary Hyperparathyroidism among Patients with Low Bone Mass. Advances in Medical Sciences, 57, 308-313.
[13] Saliba, W., Lavi, I., Rennert, H.S. and Rennert, G. (2013) The Evaluation of Vitamin D Status in Normocalcemic Primary Hyperparathyroidism. European Journal of Internal Medicine, 24, e8.
[14] Martínez Díaz-Guerra, G., Guadalix Iglesias, S. and Hawkins Carranza, F. (2013) Normocalcemic Primary Hyperparathyroidism: A Growing Problem. Medicina Clínica (Barc), 141, 125-129.

comments powered by Disqus

Copyright © 2019 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.